The National Cancer Institute (NCI) is offering grants to Small Business Innovation Research (SBIR) applicants for developing innovative technologies to enhance molecular and cellular analysis in cancer research and clinical practices. Projects should aim to address existing challenges or create novel opportunities in the field, with defined milestones for technology advancement and commercialization. This grant aligns with NCI’s Innovative Molecular Analysis Technologies (IMAT) program objectives and does not require prior participation in the program. Applicants must emphasize the unique features and benefits of their technology compared to existing methods. Deadline for submissions is January 7, 2021.
Opportunity ID: 297794
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-303 |
| Funding Opportunity Title: | Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 03, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 07, 2021 |
| Current Closing Date for Applications: | Jan 07, 2021 |
| Archive Date: | Feb 12, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) proposing research for commercial development of novel cancer-relevant technologies. The proposed research projects are expected to focus on the development of highly-innovative technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. Applications should specify milestones relevant to both the development and commercialization of these technologies. This FOA complements the goals of the NCI’s Innovative Molecular Analysis Technologies (IMAT) program by facilitating the path towards technology commercialization. Prior participation in the IMAT Program is not required for eligibility for this FOA. Applications are expected to indicate the significant attributes and advantages of the proposed technology over currently available technologies and conventional approaches. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-303.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00235427 | Oct 27, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260341 | Mar 05, 2018 | Jan 07, 2021 | View |
Package 1
Mandatory forms
297794 RR_SF424_2_0-2.0.pdf
297794 PHS398_CoverPageSupplement_4_0-4.0.pdf
297794 RR_OtherProjectInfo_1_4-1.4.pdf
297794 PerformanceSite_2_0-2.0.pdf
297794 RR_KeyPersonExpanded_2_0-2.0.pdf
297794 RR_Budget_1_4-1.4.pdf
297794 PHS398_ResearchPlan_4_0-4.0.pdf
297794 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
297794 RR_SubawardBudget30_1_4-1.4.pdf
297794 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
297794 RR_SF424_2_0-2.0.pdf
297794 PHS398_CoverPageSupplement_5_0-5.0.pdf
297794 RR_OtherProjectInfo_1_4-1.4.pdf
297794 PerformanceSite_2_0-2.0.pdf
297794 RR_KeyPersonExpanded_2_0-2.0.pdf
297794 RR_Budget_1_4-1.4.pdf
297794 PHS398_ResearchPlan_4_0-4.0.pdf
297794 SBIR_STTR_Information_1_3-1.3.pdf
297794 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
297794 RR_SubawardBudget30_1_4-1.4.pdf
297794 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
